In ovarian cancer, OSMR promotes tumor cell proliferation and metastasis by activating the STAT3 signaling pathway, and monoclonal antibodies targeting OSMR effectively suppressed cancer cell growth [51]. This evidence concerns the gene STAT3 and ovarian carcinoma.